1Hooper DC.Mechanisms of fluoroquinolone resistance[].Drug Resistance Updates.1999
2Lautenbach E,Strom BL,Bilker WB,et al.Epidemiological investigation of fluoroquinolone in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae[].Clinical Infectious Diseases.2001
3Oethinger M,Podglajen I,Kern WV,et al.Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli[].Antimicrobial Agents and Chemotherapy.1998
4Chen D,McGeer A,de Azavedo JC,et al.Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.Canadian Bacterial Surveillance Network[].The New England Journal of Medicine.1999
5Wang H,Dzink-Fox JL,Chen M,et al.Genetic Characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR Mutations[].Antimicrobial Agents and Chemotherapy.2001
6Davidson R,Cavalcanti R,Brunton JL,et al.Brief report: resistance to levofloxacin and failure of treatment of Pneumococcal pneumonia[].The New England Journal of Medicine.2002
7White DG.Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli[].Journal of Bacteriology.1997
9Goldsmith CE,Moore JE,Murphy PG,et al.Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland[].Journal of Antimicrobial Chemotherapy.1998
10Ho PL,Que TL,Tsang DN,et al.Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong[].Antimicrobial Agents and Chemotherapy.1999
